A New Anti-Diabetes Drug as a Novel Therapy for Ovarian Cancer

  • Plebanski, Magdalena (Primary Chief Investigator (PCI))
  • Gorrell, Mark (Chief Investigator (CI))
  • Oehler, Martin (Chief Investigator (CI))
  • Stephens, Andrew (Chief Investigator (CI))

Project: Research

Project Details

StatusRelinquished
Effective start/end date1/01/16 → 31/12/17

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): A$711,966.00